Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that all proposed resolutions at today’s AGM were passed, except for the proposal to cancel the shares currently held in treasury.
Cryo-Save also announces that an initial meeting has taken place with Salveo Holding S.A. (‘Salveo’), Cryo-Save’s new 27 % shareholder. Salveo has indicated to be interested in obtaining representation in the Board. The Board will shortly invite Salveo to present its plans with its investment. Cryo-Save will keep its shareholders and other stakeholders informed of significant developments and will issue additional statements if and when appropriate.
Cryo-Save Group + 31 (0) 575 509 100
Walter Van Pottelberge, Chairman